Univariate analysis demonstrated a significant impact of clinicopathologic prognostic features (i.e., AFP levels, tumor size, tumor multiplicity, clinical stage, vascular invasion and relapse) on the patient survival rates (P<0.05, Table 2). This evidence concerns the gene AFP and neoplasm.